We wish to understand how the binding of acetylcholine and other agonists by the nicotinic cholinergic receptor controls the permeability of the post-synaptic membrane and to understand how drugs and toxins interact with that receptor when they block the action of acetylcholine. Torpedo electric tissue will be fractionated to isolate post-synaptic membranes that will be used in studies of receptor structure and function. Radioligand and fluorescence binding assays will be used to define the kinetic and equilibrium binding constants characterizing receptor occupancy by agonists and antagonists. The permeability response will be measured by the flux of 22Na+ and other isotopes from the membranes. We will study the effects on the response of known concentrations of agonists and antagonists when present for times as short as 10 msec. The results of these functional studies will be used to determine how agonists binding results in the opening of the ion channel and then desensitization. We focus on the actions of amine non-competitive antagonists, including many local anesthetics, that block the action of acetylcholine by binding to a distinct """"""""anesthetic"""""""" site on the receptor. We will identify the location of the binding sites for agonists and non-competitive antagonists within the structure of the receptor. Binding sites will be labeled covalently by appropriate radiolabeled affinity reagents, and the receptor will be degraded to identify the labeled peptides in terms of the primary amino acid sequence of the receptor subunits. To determine how the ligand binding sites are oriented within the three-dimensional structure of the receptor, we will use biochemical and immunological labeling procedures to identify receptor domains that are exposed at the extracellular surface, within the lipid bilayer, or on the cytoplasmic surface. We will also determine the linear distances between the ligand binding sites, the membrane bilayer and the cytoplasmic surface of the receptor from the energy transfer observed between appropriate fluorescent labels.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS019522-05
Application #
3399587
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1982-09-01
Project End
1988-02-29
Budget Start
1986-12-01
Budget End
1988-02-29
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Kasheverov, Igor E; Chiara, David C; Zhmak, Maxim N et al. (2006) alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor. FEBS J 273:1373-88
Andreeva, Iraida E; Nirthanan, Selvanayagam; Cohen, Jonathan B et al. (2006) Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor. Biochemistry 45:195-204
Stewart, Deirdre S; Chiara, David C; Cohen, Jonathan B (2006) Mapping the structural requirements for nicotinic acetylcholine receptor activation by using tethered alkyltrimethylammonium agonists and antagonists. Biochemistry 45:10641-53
Hamouda, Ayman K; Chiara, David C; Sauls, Daniel et al. (2006) Cholesterol interacts with transmembrane alpha-helices M1, M3, and M4 of the Torpedo nicotinic acetylcholine receptor: photolabeling studies using [3H]Azicholesterol. Biochemistry 45:976-86
Chiara, David C; Trinidad, Jonathan C; Wang, Dong et al. (2003) Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist. Biochemistry 42:271-83
Sullivan, Deirdre; Chiara, David C; Cohen, Jonathan B (2002) Mapping the agonist binding site of the nicotinic acetylcholine receptor by cysteine scanning mutagenesis: antagonist footprint and secondary structure prediction. Mol Pharmacol 61:463-72
Ramarao, M K; Bianchetta, M J; Lanken, J et al. (2001) Role of rapsyn tetratricopeptide repeat and coiled-coil domains in self-association and nicotinic acetylcholine receptor clustering. J Biol Chem 276:7475-83
Xie, Y; Cohen, J B (2001) Contributions of Torpedo nicotinic acetylcholine receptor gamma Trp-55 and delta Trp-57 to agonist and competitive antagonist function. J Biol Chem 276:2417-26
Gallagher, M J; Chiara, D C; Cohen, J B (2001) Interactions between 3-(Trifluoromethyl)-3-(m-[(125)I]iodophenyl)diazirine and tetracaine, phencyclidine, or histrionicotoxin in the Torpedo series nicotinic acetylcholine receptor ion channel. Mol Pharmacol 59:1514-22
Blanton, M P; Lala, A K; Cohen, J B (2001) Identification and characterization of membrane-associated polypeptides in Torpedo nicotinic acetylcholine receptor-rich membranes by hydrophobic photolabeling. Biochim Biophys Acta 1512:215-24

Showing the most recent 10 out of 39 publications